IMFINZIの特定臨床経験調査：確定的な化学放射線療法を受けた非小細胞肺癌患者における検討

基本情報

NCT ID

NCT03643484

ステータス

完了

試験のフェーズ

-

試験タイプ

観察

目標被験者数

634

治験依頼者名

AstraZeneca

概要

To investigate the impact of presence/absence or grade of radiation pneumonitis before starting IMFINZI, on the onset of interstitial lung disease (including radiation pneumonitis) after starting IMFINZI, in the real world in patients with locally advanced unresectable non-small cell lung cancer who are treated with the product as maintenance therapy after definitive chemoradiation therapy.

対象疾患

依頼者（Sponsor）